![]() |
|
|
Vol. 289, Issue 3, 1502-1508, June 1999
Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland, Australia (R.C.H., D.J.A.); and Dipartmento Biologia Cellulare e Molecolare, Universita' di Perugia, Perugia, Italy (C.T., L.C., A.P., F.F.)
| |
Abstract |
|---|
|
|
|---|
The effects of verapamil and related phenylalkylamines on
neuronal excitability were investigated in isolated neurons of rat intracardiac ganglia using whole-cell perforated patch-clamp recording. Verapamil (
10 µM) inhibits tonic firing observed in response to
depolarizing current pulses at 22°C. The inhibition of discharge activity is not due to block of voltage-dependent Ca2+
channels because firing is not affected by 100 µM Cd2+.
The K+ channel inhibitors charybdotoxin (100 nM),
4-aminopyridine (0.5 mM), apamin (30-100 nM), and tetraethylammonium
ions (1 mM) also have no effect on firing behavior at 22°C. Verapamil
does not antagonize the acetylcholine-induced inhibition of the
muscarine-sensitive K+ current (M-current) in rat
intracardiac neurons. Verapamil inhibits the delayed outwardly
rectifying K+ current with an IC50 value of 11 µM, which is approximately 7-fold more potent than its inhibition of
high voltage-activated Ca2+ channel currents. These data
suggest that verapamil inhibits tonic firing in rat intracardiac
neurons primarily via inhibition of delayed outwardly rectifying
K+ current. Verapamil inhibition of action potential firing
in intracardiac neurons may contribute, in part, to verapamil-induced tachycardia.
| |
Introduction |
|---|
|
|
|---|
Postganglionic
neurons of mammalian intracardiac ganglia mediate vagal innervation of
the heart, forming functional afferent, efferent, and local circuits
responding to neural and humoral substances to influence heart rate
(Moravec and Moravec, 1989
; Armour, 1991
). In neonatal rat intracardiac
ganglia, >90% of neurons display tonic or slowly adapting action
potential firing in response to a depolarizing current pulse at 22°C
(Cuevas et al., 1997
). At 37°C, these neurons display rapidly
adapting action potential firing to a depolarizing current pulse. The
discharge activity of intracardiac neurons can be modulated by
acetylcholine (ACh), which is the primary neurotransmitter involved in
the vagal innervation of the heart.
Verapamil, a derivative of papaverine, is a class IV antiarrhythmic
commonly used for the treatment of supraventricular tachyarrhythmias. The antiarrhythmic effects of verapamil are most marked on the atrioventricular node, making it effective in the treatment of atrial
fibrillation and paroxysmal supraventricular tachyarrhythmias (Witt and
Cranefield, 1974
). Verapamil inhibits Ca2+ entry
through high voltage-activated L-type Ca2+
channels in cardiac myocytes to slow the firing of pacemaker cells in
the sinoatrial node, shorten the plateau phase of the action potential,
and slow impulse propagation, increasing the refractory period of the
atrioventricular node (for a review, see Nademanee and Singh, 1988
).
Several studies have recently reported that verapamil also inhibits
delayed rectifier K+ currents
[IK(DR)] in a number of tissues, including rat
alveolar epithelial cells (DeCoursey, 1995
), chick embryo dorsal root
ganglion neurons (Trequattrini et al., 1996
, 1998a
),
K+ channels cloned from human heart (Rampe et
al., 1993
), and mouse mKv1.3 channels (Rauer and Grissmer,
1996
). In the present study, the effects of verapamil on action
potential firing behavior and ionic currents were investigated in
isolated neurons from neonatal rat intracardiac ganglia. Verapamil
inhibits tonic action potential firing observed at 22°C and in the
presence of muscarinic ACh receptor stimulation. Although verapamil
partially inhibits high voltage-activated Ca2+
channel currents in rat intracardiac neurons, it attenuates action potential firing at low concentrations (
10 µM), primarily through inhibition of IK(DR). Preliminary reports of some
of these results have been published (Hogg and Adams, 1997
;
Trequattrini et al., 1998b
).
| |
Materials and Methods |
|---|
|
|
|---|
Cell Preparation.
Parasympathetic neurons from neonatal rat
intracardiac ganglia were isolated and cultured as described previously
(Xu and Adams, 1992a
). Briefly, 2- to 8-day-old rats were stunned and decapitated, and the hearts were excised and placed in a saline solution containing 140 mM NaCl, 3 mM KCl, 2.5 mM
CaCl2, 0.6 mM MgCl2, 7.7 mM
glucose, and 10 mM histidine, pH 7.2. The atria were separated, and the
medial region containing the pulmonary veins and superior vena cava was
identified, isolated, and incubated in the above saline solution,
containing 1 mg·ml
1 collagenase (Type 2, activity ~200 U·mg
1; Worthington
Biochemical Corp., Freehold, NJ). After enzyme digestion, the ganglia
were removed, and neurons were dispersed by trituration in a high
glucose culture medium [Dulbecco's modified Eagle's medium,
containing 10% (v/v) FCS, 100 U·ml
1
penicillin, and 0.1 mg·ml
1 streptomycin]
using a fire-polished pasteur pipette. The dissociated neurons were
plated onto laminin-coated glass coverslips and incubated at 37°C in
a 95% air/5% CO2 atmosphere for 24 to 72 h. For experimentation, coverslips containing dissociated neurons were
transferred to a perfusion chamber (0.5 ml volume) mounted on an
inverted microscope, and individual cells were identified under 400×
magnification using phase-contrast optics.
Electrophysiological Recording.
Current and voltage
recordings were made using the whole-cell recording configuration of
the patch-clamp technique (Hamill et al., 1981
). Electrical access to
the cell interior was obtained using either the perforated-patch
configuration (Horn and Marty, 1988
) or the conventional (dialyzed)
whole-cell recording configuration for recording voltage-dependent
Na+ and Ca2+ currents. The
perforated-patch configuration allows electrical access to the cell
interior without the loss of cytoplasmic components, which is important
in maintaining functional responses in these cells. A stock solution of
60 mg·ml
1 amphotericin B in dimethyl
sulfoxide was prepared on the day of the experiment and was diluted in
the pipette solution to yield a final concentration of 240 µg·ml
1 amphotericin B in 0.4% dimethyl
sulfoxide. The tip of the pipette first was filled with antibiotic-free
solution to prevent any disruption of seal formation and then was
backfilled with the amphotericin B-containing solution. Pipettes were
pulled from thin-walled borosilicate glass (Clark Electromedical
Instruments, Reading, UK) using a Sutter instruments P-87 pipette
puller and after fire polishing had resistances of ~1 M
. Access
resistances using the perforated patch configuration were typically 4 to 8 M
before series resistance compensation of 60% to 80%.
3 dB, Bessel filter), digitized at 10 to 50 kHz (Digidata 1200 interface; Axon Instruments Inc.), and stored on a
PC (Pentium, 100 MHz) for viewing and analysis. Voltage and current
protocols were applied, and data acquisition and analysis were carried
out using pClamp software (Version 6.1.2; Axon Instruments Inc.).
Depolarization-activated ionic currents were elicited with voltage
steps from a holding potential of
100 to
60 mV to more positive
potentials. Capacitive transients were minimized by using analog
circuitry of the amplifier, and leak currents were subtracted with a
P/4 protocol. Dose-response curves were obtained by measuring either
the peak inward Ba2+ current or steady-state
outward K+ current amplitude at each antagonist
concentration, and the experimental data points were fit using the
equation:
|
(1) |
Solutions.
The pipette filling solution for perforated patch
experiments contained 75 mM
K2SO4, 55 mM KCl, 5 mM
MgSO4, and 10 mM HEPES, titrated with
N-methyl-D-glucamine to pH 7.2. In the
dialyzed whole-cell recording configuration, the pipette solution
contained 140 mM KCl, 2 mM MgATP, 10 mM
K4-1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, and 10 mM HEPES-KOH, pH 7.2. The pipette solution used to record
voltage-activated Ca2+ channel currents using the
conventional whole-cell configuration contained 100 mM
CsCl2, 10 mM
Na4-1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, 2 mM MgATP, 0.2 mM GTP, and 40 mM HEPES-CsOH, pH 7.2. The control
extracellular solution contained 140 mM NaCl, 3 mM KCl, 2.5 mM
CaCl2, 1.2 mM MgCl2, 7.7 mM
glucose, and 10 mM HEPES-NaOH, pH 7.2. In experiments to examine
IK(DR), 300 nM tetrodotoxin (TTX) and 0.1 mM
CdCl2 were included in the extracellular
solution. Depolarization-activated Ca2+ channel
currents were isolated in the presence of 300 nM TTX, 5 mM
tetraethylammonium ions (TEA)-Cl, and 10 mM
BaCl2. The muscarine-sensitive K+ current (M-current
[IM]) was isolated as described previously using extracellular solutions containing 3 mM CsCl, 1 mM
4-aminopyridine, and 300 nM TTX (Cuevas et al., 1997
). Experiments were
carried out at 22°C except where indicated otherwise. The osmolality
of all solutions was monitored with a vapor pressure osmometer (5500; Wescor, Logan, UT) and was in the range of 285 to 295 mmol·kg
1.
Reagents. All chemicals used were of analytical grade. All drugs were applied by bath application except where indicated. The drugs methoxyverapamil hydrochloride (D600), (±)-verapamil hydrochloride, acetylcholine chloride, mecamylamine hydrochloride, apamin, TEA, ATP, and GTP were supplied by Sigma Chemical Co. (St. Louis, MO). 4-Aminopyridine (4-AP) was from Aldrich Chemical Co. (Milwaukee, WI). Charybdotoxin (ChTX) was from Auspep (Parkville, Victoria, Australia). D890 (LU 44280) was from Knoll AG-Ludwigshafen. TTX was from Calbiochem-Novabiochem Pty. Ltd.
| |
Results |
|---|
|
|
|---|
Effects of Verapamil on Action Potential and Firing Discharge Activity
The effect of verapamil on action potential firing at 22°C was
investigated using the perforated patch recording configuration in >70
neonatal rat intracardiac neurons. The average resting membrane
potential was
52 mV and was unchanged in the presence of 10 to 100 µM verapamil (data not shown). At 22°C, neonatal rat intracardiac
neurons respond to suprathreshold depolarizing current pulses with
either a slowly adapting or a tonic discharge (Fig.
1A; Cuevas et al., 1997
). Bath
application of verapamil (
10 µM) reversibly reduced the number of
action potentials in response to a 100-pA depolarizing current pulse
(Fig. 1, B and C). Verapamil also altered the action potential
waveform, whereby the peak amplitude of the afterhyperpolarization is
reduced and a slower rate of depolarization during the interspike
interval was observed (Fig. 1D). A mild slowing of the rate of action
potential repolarization (14.4 versus 19.6 mV·ms
1) was also consistently observed.
|
In contrast, at 37°C, no changes in the rate of firing were observed
in response to a depolarizing current step in the absence or presence
of 100 µM verapamil (Fig. 2, A and B).
Phasic action potential firing in rat intracardiac neurons in response
to a depolarizing current pulse has previously been attributed to the presence of an IM at 37°C (Xi-Moy and Dun,
1995
; Cuevas et al., 1997
). The application of 100 µM ACh together
with 3 µM mecamylamine (to block neuronal nicotinic ACh receptor
activation) to the cell soma at 37°C inhibits
IM and induces tonic firing (Fig. 2C). Tonic firing in the presence of ACh is reversibly inhibited in the presence of 100 µM verapamil, as shown in Fig. 2, D and E. Given that
verapamil has been reported to competitively antagonize muscarinic ACh
receptors (Karliner et al., 1982
; Baumgold, 1986
), the effect of
verapamil on IM in the absence and presence of
ACh was examined at both 22°C and 37°C. At 22°C, the kinetics of
IM are slowed and its amplitude is reduced,
resulting in tonic firing. In five cells, bath application of verapamil
(100 µM) did not affect IM or its inhibition by
ACh (100 µM ACh plus 3 µM mecamylamine). ACh reduced IM by approximately 30% in the absence and
presence of 100 µM verapamil at both temperatures (n = 5, data not shown).
|
To assess the effect of a Ca2+ channel blocker on
action potential firing at 22°C, 0.1 mM Cd2+,
which completely blocks depolarization-activated
Ca2+ currents in rat intracardiac neurons (Xu and
Adams, 1992b
; Jeong and Wurster, 1997
), was bath applied and had no
effect on firing behavior (n = 6, data not shown).
Similarly, the K+ channel inhibitors ChTX (100 nM), 4-AP (0.5 mM), apamin (30-100 nM), and TEA (1 mM) also had no
effect on action potential firing (Cuevas et al., 1997
). The effect of
verapamil on voltage-dependent Na+ currents was
also examined in rat intracardiac neurons, but these currents were
unaffected by bath application of 10 to 100 µM verapamil (n = 4; data not shown).
Effects of Verapamil on Voltage-Activated Ca2+ and K+ Channel Currents
The effect of verapamil on the high voltage-activated
Ca2+ channel current in rat intracardiac neurons
is shown in Fig. 3A. Bath application of
10 to 300 µM verapamil reversibly inhibited the
Ba2+ current elicited by step depolarization from
100 mV to +20 mV. Verapamil inhibits the Ba2+
current in a concentration-dependent manner with an
IC50 value of 78 µM (n
4;
Fig. 3B). The inward Ba2+ current remaining in
the presence of 0.3 to 1 mM verapamil was completely inhibited by 100 µM Cd2+ (Fig. 3A).
|
Bath application of verapamil inhibited IK(DR) in
a concentration-dependent manner as shown in Fig.
4A. Verapamil induced a rapid,
dose-dependent decay of the current to a new steady-state level without
affecting its rising rate, suggesting a state-dependent block. A
dose-response curve was obtained by applying depolarizing voltage
pulses of sufficient duration (225-500 ms) to reach steady-state block
in the presence of varying concentrations of verapamil. Half-maximal
inhibition of IK(DR) by verapamil occurred at 11 µM (n
3; Fig. 4B), which is approximately 7-fold
more potent than that for verapamil inhibition of high
voltage-activated Ca2+ channel currents.
|
The effect of the related phenylalkylamines, D600 and its permanently
charged quaternary derivative D890, on action potential firing and
IK(DR) was also examined. Bath application of 100 µM D890 did not affect firing in response to a depolarizing current pulse (Fig. 5B), whereas 100 µM D600
attenuated discharge activity (Fig. 5C). The relative abilities of 100 µM D600 and D890 to inhibit IK(DR) are compared
in Fig. 5D. Under voltage-clamp conditions, the amplitude of
IK(DR) elicited on depolarization to +80 mV was reduced in the presence of D600 but not D890 (Fig. 5D). The ability of
the phenylalkylamines to reduce action potential firing appears to
correlate with their potency to inhibit IK(DR).
|
Verapamil Block of Delayed-Rectifier K+ Currents
Given that verapamil block of IK(DR) appears
to underlie the inhibition of action potential firing, the
characteristics of verapamil block of IK(DR) were
investigated. Figure 6 shows the effects
of 30 µM verapamil on IK(DR) evoked by
depolarizing pulses from a holding potential of
80 mV to test
potentials between
40 and +80 mV. As also shown at voltages positive
to 0 mV (see Fig. 4A), verapamil caused a dramatic change in the time
course of IK(DR); the current activated to a
maximum then decayed with time to a small fraction of its peak value
(Fig. 6B). In contrast, no change was observed in the activation
kinetics of the current. The decay of the current was well fitted by a
single exponential.
|
Figure 6C shows the activation curve of the
IK(DR) (filled symbols) together with the
steady-state fractional block of the current as a function of the
membrane potential (open symbols). Block increased steeply between
20
mV and +20 mV, the voltage range of channel activation, whereas it was
approximately stable at membrane potentials more positive than +40 mV,
where all channels are open. This indicates that block may be directly
linked to the gating process (compare with Snyders et al., 1991
), as
expected for a state-dependent block in which the drug can bind to the channel only in the open state according to the kinetic scheme:
|
(2) |
,
,
kon, and
koff are the rate constants for the
transitions between states. A prediction of this model is that the rate
of current decay is dependent on the blocker concentration. This
prediction is tested by an experiment of the type shown in Fig. 4A. The
plot shown in Fig. 6D demonstrates that the decay rate (1/
) exhibits
a linear dependence on verapamil concentration.
Kinetic Constants of Verapamil Block
The block and unblock rate constants,
kon and
koff, were estimated from the
verapamil-induced current decay (Fig. 6D) as previously described for
verapamil block of IK(DR) (Rampe et al., 1993
;
Trequattrini et al., 1998a
). Interference from the concurrent
inactivation process (
3-4 s) can be neglected compared with
the much faster current decay (
b < 150 ms)
induced by verapamil. Given that at high depolarizing voltages (+80 mV)
channel activation occurs with a time constant (<4 ms) more than
3-fold lower than
b, the decay of the current
in the presence of verapamil represents the process of channel block.
Under these conditions, block and unblock rate constants can be
estimated using the relation 1/
b = (kon[B] + koff), where
b is the time constant of verapamil-induced
current decay. Using this relation,
kon and
koff values are obtained from the
slope and the intercept, respectively, of the linear regression of
1/
b versus verapamil concentration. The block
and unblock rate constants obtained from five neurons were 0.67 ± 0.04 ms
1·mM
1 and
0.0075 ± 0.008 ms
1, respectively. These
rate constants give a value of 11 µM for the dissociation constant
(KD = koff/kon),
consistent with that obtained from steady-state measurements.
Voltage Dependence of Block and Unblock Rate Constants
The voltage dependence of verapamil block was assessed from the
rate of block, 1/
b, and from the steady-state
block, IVerapamil/IControl, at different voltages. To minimize possible errors in the measurement of the voltage dependence of block introduced by the shift in gating
equilibrium (see Trequattrini et al., 1996
), test pulses to voltages
between +105 and +45 mV (15-mV steps) were preceded by a depolarizing
prepulse (+120 mV, for 25 ms) where channel activation was maximal
under control conditions (Fig. 7A). This protocol would rapidly activate all channels, thus uncoupling the
activation process from block. The block rate constants, after the
addition of 30 µM verapamil, were assessed by solving the equation
given by the time constant of block (1/
b = (kon[B] + koff) and the steady-state block
{IVerapamil/IControl = 1/(1+ [B]/[koff/kon])}
at varying test voltages (assuming that block involves the binding of
one molecule per channel). The rate constants kon and
koff were found to be uniform over the
voltage range examined (Fig. 7B), indicating verapamil block is not
voltage dependent. This method was used because it allows
kon and
koff to be calculated at various
potentials using only one concentration of verapamil. The estimate of
kon and
koff, as they appear in Fig. 7B are
consistent with those derived from Fig. 6D using the method described
previously.
|
The time course of recovery from block by verapamil occurring at
repolarized potentials was assessed by using a double-pulse protocol.
The recovery during the interpulse period at
80 mV was measured as
the ratio between the peak current of the second (test) pulse and the
peak current of the first (conditioning) pulse. Figure 7C shows that
recovery from block follows a double exponential time course with time
constants of 0.4 and 4.12 s. The effects of increased external
K+ concentration on the onset and recovery from
block were also examined because external
K+ has been shown to rise considerably during
prolonged firing and has been shown to significantly affect the
kinetics of block in several preparations (Armstrong, 1971
; DeCoursey,
1995
). Raising external K+ to 30 mM did not
significantly change either the decay rate of IK(DR) or recovery from block by verapamil (data
not shown).
| |
Discussion |
|---|
|
|
|---|
Verapamil (1-100 µM) reversibly attenuates tonic action
potential firing observed in neonatal rat intracardiac neurons both at
22°C and after muscarinic receptor stimulation at 37°C. which may
occur in vivo during prolonged vagal stimulation. Verapamil, however,
has no effect on rapidly adapting firing observed in response to
depolarizing current pulses at 37°C. The firing behavior of neonatal
rat intracardiac neurons is highly temperature dependent and modulated
by ACh via IM (Cuevas et al., 1997
). At 37°C,
neurons rapidly adapt in response to a depolarizing current step, but in the presence of ACh or a muscarinic receptor agonist,
IM is depressed and a depolarizing current step
elicits tonic action potential firing. IM is
largely inactivated at 22°C, and in response to membrane
depolarization, neurons fire repetitively. Verapamil has been reported
to antagonize the binding of agonists to muscarinic ACh receptors in
rat brain (Baumgold, 1986
; Katayama et al., 1987
) and heart (Karliner
et al., 1982
) and muscarinic ACh receptor activation of
K+ currents in guinea pig atrial myocytes (Ito et
al., 1989
). In rat intracardiac neurons, verapamil failed to have any
effect on IM in the absence or presence of ACh,
suggesting that verapamil inhibition of ACh-induced tonic firing
observed in these neurons at 22° and 37°C is not due to antagonism
of muscarinic receptor activation. The inhibition of ACh-induced firing
by verapamil appears to involve a verapamil-sensitive current other
than IM that may also modulate neuronal
excitability in rat intracardiac ganglia.
The inhibition of discharge activity is not due to block of
voltage-gated Ca2+ or
Ca2+-dependent K+ channels
because firing is not affected by 0.1 mM Cd2+,
100 nM ChTX, 0.5 mM 4-AP, 30-100 nM apamin, and 1 mM TEA. Given that
voltage-dependent Na+ currents and
IM are also unaffected by verapamil, inhibition of the discharge activity in these neurons by verapamil most likely occurs through block of IK(DR). Inhibition of
IK(DR) by verapamil occurs with an
IC50 value of 11 µM, which is similar to that
determined in chick DRG neurons (4 µM; Trequattrini et al., 1996
) and
for delayed rectifier K+ channels cloned from
human heart (21 µM; Rampe et al., 1993
).
An effect attributable to IK(DR) inhibition is the reduced amplitude of the action potential afterhyperpolarization, which will slow the rate of Na+ channel (voltage-dependent) recovery from inactivation and increase the threshold for action potential firing. This effect of verapamil on Na+ current time course, secondary to IK(DR) inhibition, is consistent with a slower rate of depolarization and reduced overshoot of the subsequent action potential (see Fig. 1). The slower rate of depolarization associated with the increased interval between action potentials observed in the presence of verapamil may also be due, in part, to inhibition of the voltage-activated Ca2+ conductance, which would be reduced ~15% by 10 µM verapamil. An IC50 value of 78 µM was obtained for verapamil inhibition of the depolarization-activated Ba2+ current, indicating that verapamil is approximately 7-fold more potent in inhibiting IK(DR) compared with high voltage-activated Ca2+ channel currents.
The phenylalkylamine D600, but not the permanently charged D890,
inhibited tonic action potential firing at 22°C with similar potency
to their inhibitory effects on IK(DR). The
effectiveness of the different phenylalkylamines to block
IK(DR) also correlates with their ability to
cross the plasma membrane, suggesting that the binding site on the
IK(DR) channel is not located on the external part of the channel. Externally applied verapamil has been proposed to
reach an internal binding site by partitioning into the lipid phase of
the membrane (DeCoursey, 1995
). Furthermore, the verapamil binding site
on IK(DR) channels has been identified as part of the inner mouth of the K+ channel pore (Rampe et
al., 1993
).
The block of IK(DR) by verapamil is consistent
with a state-dependent block in which the drug binds preferentially to
the open state of the IK(DR) channel as reported
previously (Rampe et al., 1993
; DeCoursey, 1995
; Trequattrini et al.,
1996
). However, the biexponential time course of recovery from block
(see Fig. 7C) is not compatible with this simple three-state model
unless an additional state, into which open-blocked channels can pass, is included. Previous studies have suggested such an additional state
to be either an inactivated-blocked state (DeCoursey, 1995
) or a
closed-blocked state (Armstrong, 1971
; Trequattrini et al., 1998a
). The
block of IK(DR) in rat intracardiac ganglion
neurons has similar kinetics to that seen in chick embryo DRG neurons (Trequattrini et al., 1998a
) and rat alveolar epithelial cells (DeCoursey, 1995
).
Inhibition of action potential firing in parasympathetic neurons of
intracardiac ganglia may be expected to reduce the bradycardia associated with vagal nerve stimulation in vivo, leading to
tachycardia. Verapamil has been shown to cause a
concentration-dependent increase in heart rate in conscious dogs
(Nakaya et al., 1983
) and has been reported to inhibit the bradycardic
response to stimulation of the right vagal nerve in anesthetized
neonatal pigs (Lee et al., 1985
). Tachycardia, which is often observed
on administration of verapamil to conscious animals, can be inhibited
by autonomic block with atropine and propranolol but not with
propranolol alone (Nakaya et al., 1983
). The present data indicate that
verapamil-induced inhibition of action potential firing in
parasympathetic neurons may contribute, in part, to verapamil-induced tachycardia.
| |
Footnotes |
|---|
Accepted for publication February 22, 1999.
Received for publication February 22, 1999.
1 This work was supported by National Health and Medical Research Council of Australia Grant 961138 (to D.J.A.) and Grant 92.689.CT04 from Italian Consiglio Nazionale Ricerch (to F.F.).
Send reprint requests to: Dr. David J. Adams, Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland 4072, Australia. E-mail: dadams{at}plpk.uq.edu.au
| |
Abbreviations |
|---|
ACh, acetylcholine; IK(DR), delayed rectifier K+ currents; IM, muscarine-sensitive K+ current; TTX, tetrodotoxin; TEA, tetraethylammonium ions; D600, methoxyverapamil hydrochloride; 4-AP, 4-aminopyridine; ChTX, charybdotoxin.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. Zhang and J. Cuevas {sigma} Receptor Activation Blocks Potassium Channels and Depresses Neuroexcitability in Rat Intracardiac Neurons J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1387 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sculptoreanu, N. Yoshimura, and W. C. de Groat KW-7158 [(2S)-(+)-3,3,3-Trifluoro-2-hydroxy-2-methyl-N-(5,5,10-trioxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)propanamide] Enhances A-Type K+ Currents in Neurons of the Dorsal Root Ganglion of the Adult Rat J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 159 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rybalchenko, N. Prevarskaya, F. Van Coppenolle, G. Legrand, L. Lemonnier, X. Le Bourhis, and R. Skryma Verapamil Inhibits Proliferation of LNCaP Human Prostate Cancer Cells Influencing K+ Channel Gating Mol. Pharmacol., June 1, 2001; 59(6): 1376 - 1387. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||